EGFR and EGFRvIII coopt host defense pathways, promoting progression in glioblastoma

To investigate the function of TLR2 in EGFR and EGFRvIII co-expressing glioblastoma cells, we knocked out TLR2 by CRISPR. Overall design: We then performed gene expression profiling analysis using data obtained from RNA-seq of the cells.